Huntington's disease trials in Spain

In Spain 8 Also abroad 51

8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2/3Taking people
Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
Where
Barcelona, Madrid
Age
25 years and over
People
400 worldwide
Run by
Skyhawk Therapeutics, Inc.
See details and how to joinNCT07378644 · EU 2025-522263-14-00
Phase 3Taking people
Pridopidine Phase 3 Study in Huntington's Disease
Where
Barakaldo, Barcelona, Madrid, Oviedo, Sevilla
Age
23 years to 65 years
People
400 worldwide
Run by
Prilenia
See details and how to joinNCT07609108 · EU 2026-526093-16-00
No phaseNot yet taking people in Spain
Creatine and Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation Plus Home-Based Exercise for Sarcopenia in Huntington's Disease
Where
Burgos
Age
18 years and over
People
88
Run by
Universidad de Burgos
See details and how to joinNCT07902206
Phase 3Taking people
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Where
Badajoz, Barakaldo, Barcelona, Burgos, L'hospitalet De Llobregat, Madrid, Málaga, Palma, Sevilla, Valencia
Age
21 years to 70 years
People
770 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07326709 · EU 2025-522227-99-00
No phaseTaking people
HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
Where
Barcelona, Bilbao, Madrid
Age
11 years to 75 years
People
2,500 worldwide
Run by
University College, London
See details and how to joinNCT02855476
Phase 2Taking people
Trial of the Combined Use of Thiamine and Biotin in Patients With Huntington's Disease
Where
Donostia, Sevilla, Hospital Ramón y Cajal (Madrid, SPAIN)
Age
18 years and over
People
24
Run by
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
See details and how to joinNCT04478734 · EU 2023-508637-14-00
Phase 3Taking people
Randomised, double-blind, placebo-controlled study to evaluate the effect of metformin, an AMPK activator, on cognitive measures of progression in Huntington's disease patients.
Where
Albacete, Alicante, Barcelona, Burgos, Elche, Madrid, Oviedo, Palma, Valencia
Age
18 years and over
People
60
Run by
IIS La Fe
See details and how to join2024-518875-73-00 · EU 2024-518875-73-00
No phaseTaking people
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Where
Badajoz, Barakaldo, Barcelona, Burgos, Madrid, Palma de Mallorca, Pamplona, Valencia
Age
18 years and over
People
35,000 worldwide
Run by
CHDI Foundation, Inc.
See details and how to joinNCT01574053